Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer?

Lignende værker

• Smoking history and the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
  af: Chen, Da-Li, et al.
  Udgivet: (2021)
• Immune Checkpoint Inhibitors in Advanced-Stage Non-small Cell Lung Cancer
  af: Kazaz, Seher Nazlı, et al.
  Udgivet: (2017)
• A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer
  af: Chiu, Michelle, et al.
  Udgivet: (2020)
• Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
  af: Walsh, Robert J., et al.
  Udgivet: (2020)
• Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer
  af: Pradhan, Monika, et al.
  Udgivet: (2021)